Campaign: Areas of Interest for Cancer Nanotechnology

Robust, Reproducible Methods for Making Targeted Nanoparticles

From an industry perspective, a potential bottleneck that will need to be overcome in bringing targeted nanoparticles from the bench to the bedside is scale-up. Existing academic laboratory environments are adequate for manufacturing enough targeted nanoparticles for ongoing preclinical studies (in vitro and in vivo). However, human studies and clinical use will require far greater quantity of targeted nanoparticles and ...more »

Submitted by

Voting

6 votes
6 up votes
0 down votes
Active